GlassScriptPhysician profile
Darryl A Hooker
NPI 1821402165
$2,887.60
in general payments reported to CMS, 2019-2025
15 companies · $750 in 2025
The $750 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $330 · 2022: $457 · 2023: $818 · 2024: $532 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,079 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,079.16 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,306.62 | 2021-2025 | |
| Lilly USA, LLC | $623.04 | 2021-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $204.93 | 2024-2025 | Wegovy, Saxenda |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.90 | 2022-2025 | Jardiance |
| Abbott Laboratories | $138.62 | 2022-2024 | Freestyle Libre 3 |
| Indivior INC. | $107.27 | 2024 | Sublocade |
| Almatica Pharma LLC | $72.36 | 2022-2023 | Gralise, Loreev Xr |
| Pfizer INC. | $64.05 | 2023-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $51.80 | 2022-2024 | Caplyta |
| Hologic Sales and Service, LLC | $51.23 | 2021-2025 | Aptima |
| Amgen INC. | $39.04 | 2025 | Repatha |
| Alkermes, INC. | $25.35 | 2025 | Vivitrol |
| Hikma Pharmaceuticals USA | $21.00 | 2023 | Kloxxado |
| Arbor Pharmaceuticals, INC. | $18.39 | 2021 | |
| Allergan, INC. | $17.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darryl Hooker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.